n(g),n(g')-dimethyl-l-arginine has been researched along with Pregnancy in 83 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Resveratrol, a phytochemical, has shown antioxidant properties and potential benefits in hypertension." | 8.02 | Maternal resveratrol therapy protected adult rat offspring against hypertension programmed by combined exposures to asymmetric dimethylarginine and trimethylamine-N-oxide. ( Chan, JYH; Chang-Chien, GP; Hou, CY; Hsu, CN; Lee, CT; Lin, S; Tain, YL, 2021) |
| "To evaluate the sequential trend of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in pregnancies developing preeclampsia (PE) as compared to healthy pregnancy (HP) and to estimate their predictive value for development of PE later in pregnancy." | 7.88 | Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia. ( Deepak, KK; Garg, P; Jaryal, AK; Kachhawa, G; Kriplani, A, 2018) |
| "Our previous study suggested that a lower l-arginine level (<70μM) at early gestation is associated with pregnancy-induced hypertension." | 7.85 | Association of serum asymmetric dimethylarginine, homocysteine, and l-arginine concentrations during early pregnancy with hypertensive disorders of pregnancy. ( Imai, K; Kajiyama, H; Kikkawa, F; Kotani, T; Maruta, E; Mitsui, T; Nakano, T; Nawa, A; Niwa, Y; Sumigama, S; Tamakoshi, K; Tsuda, H; Wang, J; Yamashita, M; Yoshida, S, 2017) |
| "To evaluate the usefulness of serial determinations of asymmetric dimethylarginine (ADMA) and homocysteine (Hcy) concentrations during pregnancy to predict pre-eclampsia, taking into account maternal obesity and B vitamin status." | 7.81 | Serial determinations of asymmetric dimethylarginine and homocysteine during pregnancy to predict pre-eclampsia: a longitudinal study. ( Hinojosa-Cruz, JC; Leaños-Miranda, A; López-Alarcón, M; Martínez-Basila, A; Montalvo-Velarde, I; Vital-Reyes, VS, 2015) |
| " Asymmetric dimethylarginine (ADMA) is increased in diabetes mellitus, kidney disease, and hypertension." | 7.79 | Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers. ( Hsu, CN; Huang, LT; Lee, CT; Lee, WC; Lin, CY; Tain, YL, 2013) |
| "These findings provide support for the hypothesis that elevated levels of asymmetric dimethylarginine in pregnancy complicated by preeclampsia are associated with elevated homocysteine levels." | 7.79 | Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction. ( Laskowska, K; Laskowska, M; Oleszczuk, J, 2013) |
| "The aim of this study was to investigate maternal asymmetric dimethylarginine (ADMA) concentrations at the three trimesters of pregnancy in uncomplicated pregnancies and in women who developed preeclampsia or had small for gestational age infants (SGA) without preeclampsia." | 7.78 | Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. ( Batakis, E; Botsis, D; Eleftheriades, M; Haliassos, A; Hassiakos, D; Rizos, D; Rizou, M, 2012) |
| " We analyzed the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and asymmetric dimethylarginine (ADMA) in 55 Turkish patients with PE without fetal growth retardation (FGR) and in 54 healthy pregnant women." | 7.76 | Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation. ( Ateş, K; Ilhan, N; Kafkasli, A; Kaman, D; Turan, F, 2010) |
| "The purpose of this study was to investigate maternal plasma concentrations of asymmetric dimethylarginine (ADMA) in mid pregnancy and at the time of disease in women who experience preeclampsia, compared with women with uncomplicated pregnancies and women with small-for-gestational-age infants." | 7.74 | Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. ( Frank, MP; Harger, G; Markovic, N; Powers, RW; Roberts, JM; Speer, PD, 2008) |
| "Preeclampsia is a serious, pregnancy-specific, multi-organ disease process of compound aetiology." | 6.61 | The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia-Review. ( Dymara-Konopka, W; Laskowska, M, 2019) |
| "Preeclampsia is a major cause of maternal and neonatal morbidity and mortality worldwide." | 6.46 | The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. ( Böger, RH; Diemert, A; Hecher, K; Lüneburg, N; Maas, R; Schwedhelm, E, 2010) |
| " These data define a role for dysregulation of NO biosynthetic pathways in the pathogenesis of MIP and support the evaluation of interventions to enhance l-arginine bioavailability as strategies to improve birth outcomes." | 5.48 | Malaria in pregnancy alters l-arginine bioavailability and placental vascular development. ( Cahill, LS; Conroy, AL; Elphinstone, R; Gamble, JL; Gazdzinski, LM; Kain, KC; Kalilani-Phiri, L; Madanitsa, M; McDonald, CR; Mwapasa, V; Philson, AC; Sled, JG; Ter Kuile, FO; Zhong, KJY, 2018) |
| "Preeclampsia is associated with an imbalance in vasoactive factors, including nitric oxide (NO), hydrogen sulfide (H2S), and renin-angiotensin system (RAS)." | 5.43 | N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers. ( Hsu, CN; Lee, CT; Lin, YJ; Tain, YL; Tsai, CC, 2016) |
| "Decreased DDAH and HO with preeclampsia suggest that they are important points in the regulatory pathways of NO and CO production that are altered in preeclampsia." | 5.39 | Nitric oxide and carbon monoxide production and metabolism in preeclampsia. ( Chan, K; Chen, DB; Ehsanipoor, RM; Fitzmaurice, LE; Fortson, W; Liao, WX; Wing, DA, 2013) |
| "Preeclampsia is a syndrome characterized by hypertension and proteinuria." | 5.37 | The role of asymmetric dimethyl arginine and oxidant/antioxidant system in preeclampsia. ( Akalin, S; Akgul, EO; Alacam, H; Aydin, I; Cakir, E; Danisman, N; Deren, O; Dikmen, ZG; Dogan, P; Keskin, U; Kurt, YG; Polat, B; Yaman, H, 2011) |
| "Preeclampsia is a leading cause of intrauterine growth restriction and preterm birth." | 5.35 | Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. ( Braekke, K; Harsem, NK; Staff, AC; Ueland, PM, 2009) |
| " The reduced bioavailability of endothelium-derived nitric oxide (NO) may play a role in endothelial vasodilator dysfunction and the structural changes that are characteristic of GCAD." | 5.33 | Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. ( Cooke, JP; Gunawan, F; Jacobi, J; Robbins, RC; Sydow, K; Tanaka, M; Tsao, PS, 2005) |
| "Asymmetric dimethylarginine (ADMA) is a competitive endogenous inhibitor of nitric oxide synthase with a key role in the pathophysiology of endothelial dysfunction, in the progression of atherosclerosis and in cardiovascular diseases." | 4.91 | Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches. ( Georgakis, MK; Latsios, G; Oikonomou, E; Papageorgiou, N; Papaioannou, S; Siasos, G; Tousoulis, D; Zaromitidou, M, 2015) |
| "Resveratrol, a phytochemical, has shown antioxidant properties and potential benefits in hypertension." | 4.02 | Maternal resveratrol therapy protected adult rat offspring against hypertension programmed by combined exposures to asymmetric dimethylarginine and trimethylamine-N-oxide. ( Chan, JYH; Chang-Chien, GP; Hou, CY; Hsu, CN; Lee, CT; Lin, S; Tain, YL, 2021) |
| "To evaluate the sequential trend of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in pregnancies developing preeclampsia (PE) as compared to healthy pregnancy (HP) and to estimate their predictive value for development of PE later in pregnancy." | 3.88 | Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia. ( Deepak, KK; Garg, P; Jaryal, AK; Kachhawa, G; Kriplani, A, 2018) |
| "Our previous study suggested that a lower l-arginine level (<70μM) at early gestation is associated with pregnancy-induced hypertension." | 3.85 | Association of serum asymmetric dimethylarginine, homocysteine, and l-arginine concentrations during early pregnancy with hypertensive disorders of pregnancy. ( Imai, K; Kajiyama, H; Kikkawa, F; Kotani, T; Maruta, E; Mitsui, T; Nakano, T; Nawa, A; Niwa, Y; Sumigama, S; Tamakoshi, K; Tsuda, H; Wang, J; Yamashita, M; Yoshida, S, 2017) |
| " Maternal characteristics, uterine artery pulsatility index (UtA-PI), ductus venosus pulsatility index (DV-PI) and serum biomarkers including pregnancy associated plasma protein - A (PAPP-A), placental growth factor (PlGF), soluble fms-like tyrosine kinase 1 (sFlt-1), s-Flt-1/PLGF ratio, asymmetric dimethylarginine (ADMA), matrix metalloproteinase 9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and MMP-9/NGAL complex were recorded." | 3.83 | Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study. ( Eleftheriades, MI; Haliassos, AD; Karampas, GA; Mastorakos, GP; Metallinou, DK; Panoulis, KC; Rizos, DA; Rizou, MD, 2016) |
| "To evaluate the usefulness of serial determinations of asymmetric dimethylarginine (ADMA) and homocysteine (Hcy) concentrations during pregnancy to predict pre-eclampsia, taking into account maternal obesity and B vitamin status." | 3.81 | Serial determinations of asymmetric dimethylarginine and homocysteine during pregnancy to predict pre-eclampsia: a longitudinal study. ( Hinojosa-Cruz, JC; Leaños-Miranda, A; López-Alarcón, M; Martínez-Basila, A; Montalvo-Velarde, I; Vital-Reyes, VS, 2015) |
| "These findings provide support for the hypothesis that elevated levels of asymmetric dimethylarginine in pregnancy complicated by preeclampsia are associated with elevated homocysteine levels." | 3.79 | Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction. ( Laskowska, K; Laskowska, M; Oleszczuk, J, 2013) |
| "The present case-control study was undertaken to investigate l-arginine metabolism in pregnant women with early-onset and late-onset pre-eclampsia." | 3.79 | L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies. ( Bode-Böger, SM; Bódis, J; Hantosi, E; Kovács, GL; Martens-Lobenhoffer, J; Molnár, G; Sulyok, E; Tamás, P, 2013) |
| " Asymmetric dimethylarginine (ADMA) is increased in diabetes mellitus, kidney disease, and hypertension." | 3.79 | Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers. ( Hsu, CN; Huang, LT; Lee, CT; Lee, WC; Lin, CY; Tain, YL, 2013) |
| "The aim of this study was to investigate maternal asymmetric dimethylarginine (ADMA) concentrations at the three trimesters of pregnancy in uncomplicated pregnancies and in women who developed preeclampsia or had small for gestational age infants (SGA) without preeclampsia." | 3.78 | Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. ( Batakis, E; Botsis, D; Eleftheriades, M; Haliassos, A; Hassiakos, D; Rizos, D; Rizou, M, 2012) |
| "02) rose with fetal growth restriction while asymmetric dimethylarginine decreased (p = 0." | 3.78 | Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. ( Begliuomini, S; Boldrini, A; Casarosa, E; Coceani, F; Fink, B; Genazzani, AR; Ghirri, P; Pisaneschi, S; Ripoli, A; Sanchez, AM; Simoncini, T; Strigini, FA, 2012) |
| "We aimed to evaluate plasma asymmetric dimethylarginine (ADMA) concentrations and its relation with insulin sensitivity/resistance indices in pregnant women with different degrees of carbohydrate intolerance." | 3.77 | Asymmetric dimethylarginine level in hyperglycemic gestation. ( Kafkasli, A; Karabulut, AB; Sertkaya, AC; Turkcuoglu, I, 2011) |
| " In our study, we investigated ADMA, hCRP, and homocysteine concentrations in women with gestational diabetes mellitus (GDM) and normal glucose tolerance (NGT) during late pregnancy." | 3.76 | Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes. ( Akturk, M; Altinova, A; Arslan, M; Buyukkagnici, U; Danisman, N; Dincel, A; Mert, I; Sargin, A, 2010) |
| " We analyzed the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and asymmetric dimethylarginine (ADMA) in 55 Turkish patients with PE without fetal growth retardation (FGR) and in 54 healthy pregnant women." | 3.76 | Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation. ( Ateş, K; Ilhan, N; Kafkasli, A; Kaman, D; Turan, F, 2010) |
| "Evidence exists for an association between use of vitamin supplements with folic acid in early pregnancy and reduced risk for offspring with cleft lip with/without cleft palate (CLP)." | 3.75 | Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate. ( Blom, H; Carmichael, SL; Finnell, RH; Shaw, GM; Ueland, PM; Vollset, SE; Yang, W, 2009) |
| " However, it is unknown whether excess weight, insulin resistance, and asymmetric dimethylarginine (ADMA)--an endogenous nitric oxide (NO) synthase inhibitor--also contribute to the vascular changes observed in these patients." | 3.74 | Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes. ( Kautzky-Willer, A; Langenberger, H; Mittermayer, F; Pacini, G; Pleiner, J; Schaller, G; Tura, A; Winzer, C; Wolzt, M, 2007) |
| "The purpose of this study was to investigate maternal plasma concentrations of asymmetric dimethylarginine (ADMA) in mid pregnancy and at the time of disease in women who experience preeclampsia, compared with women with uncomplicated pregnancies and women with small-for-gestational-age infants." | 3.74 | Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. ( Frank, MP; Harger, G; Markovic, N; Powers, RW; Roberts, JM; Speer, PD, 2008) |
| "An endogenous inhibitor of nitric oxide synthase (NOS), NG,NG dimethylarginine (asymmetric dimethylarginine, ADMA), which is present in human plasma and urine, has been reported to be elevated in the plasma of women with pre-eclampsia." | 3.69 | Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and pre-eclamptic placentae. ( Brennecke, SP; Di Iulio, JL; Gude, NM; King, RG, 1995) |
| "Since women with gestational diabetes mellitus (GDM) are at high risk of future CVD, we conducted a systematic review and meta-analysis to compare ADMA concentrations between women with and without GDM during pregnancy and postpartum." | 3.01 | Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis. ( Andraweera, PH; Arstall, MA; Kosmider, L; Lassi, ZS; Tiong, P, 2023) |
| "Preeclampsia is a serious, pregnancy-specific, multi-organ disease process of compound aetiology." | 2.61 | The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia-Review. ( Dymara-Konopka, W; Laskowska, M, 2019) |
| "Low and high birth weights have been linked to increased susceptibility to cardiovascular and metabolic alterations." | 2.50 | Is asymmetric dimethylarginine associated with being born small and large for gestational age? ( Chiarelli, F; Chiavaroli, V; de Giorgis, T; Diesse, L; Giannini, C; Marcovecchio, ML; Mohn, A, 2014) |
| "Preeclampsia is a major cause of maternal and neonatal morbidity and mortality worldwide." | 2.46 | The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. ( Böger, RH; Diemert, A; Hecher, K; Lüneburg, N; Maas, R; Schwedhelm, E, 2010) |
| "Elevated ADMA levels in preeclampsia are seen before clinical symptoms have developed; these findings suggest that ADMA has a role in the pathogenesis of preeclampsia." | 2.43 | Endogenous inhibitors of nitric oxide and preeclampsia: a review. ( Dekker, G; Jeffries, B; Slaghekke, F, 2006) |
| "Smoking during pregnancy has harmful effects on the fetus and infant." | 1.62 | Evaluation of Plasma Asymmetric Dimethylarginine Levels and Abdominal Aortic Intima-Media Thickness in Infants of Smoker Mothers. ( Arslan, D; Deniz, CD; Gunenc, O; Ozcelik, HS; Uysal, C; Vatansev, H, 2021) |
| " These data define a role for dysregulation of NO biosynthetic pathways in the pathogenesis of MIP and support the evaluation of interventions to enhance l-arginine bioavailability as strategies to improve birth outcomes." | 1.48 | Malaria in pregnancy alters l-arginine bioavailability and placental vascular development. ( Cahill, LS; Conroy, AL; Elphinstone, R; Gamble, JL; Gazdzinski, LM; Kain, KC; Kalilani-Phiri, L; Madanitsa, M; McDonald, CR; Mwapasa, V; Philson, AC; Sled, JG; Ter Kuile, FO; Zhong, KJY, 2018) |
| "Since the diagnosis of gestational diabetes mellitus (GDM) identifies a patient population at increased future risk of cardiovascular disease later in life, we sought to characterize arginine metabolism in women with and without a history of recent GDM." | 1.46 | Asymmetric dimethylarginine and arginine metabolites in women with and without a history of gestational diabetes. ( Arya, S; Connelly, PW; Hanley, AJ; Retnakaran, R; Sermer, M; Ye, C; Zinman, B, 2017) |
| "Early-onset and late-onset preeclampsia are both characterized by increased systemic vascular resistance and elevated levels of nitric oxide synthesis inhibitors." | 1.46 | Systemic vascular resistance and endogenous inhibitors of nitric oxide synthesis in early- compared to late-onset preeclampsia: preliminary findings. ( Lackner, HK; Lucovnik, M; Moertl, MG; Papousek, I; Roessler, A; Schmid-Zalaudek, K; Schulter, G, 2017) |
| "Preeclampsia is associated with an imbalance in vasoactive factors, including nitric oxide (NO), hydrogen sulfide (H2S), and renin-angiotensin system (RAS)." | 1.43 | N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers. ( Hsu, CN; Lee, CT; Lin, YJ; Tain, YL; Tsai, CC, 2016) |
| "Preeclampsia is a pregnancy-related pathological condition triggered by an abnormal placentation which produces endothelial dysfunction (ED)." | 1.42 | [Interactions between markers of endothelial damage (homocysteine and asymmetric dimethylarginine) and antioxidants and B-vitamins in preeclamptic women]. ( Hinojosa-Cruz, JC; López-Alarcón, M; Montalvo-Velarde, I; Puellotamara, E; Vital-Reyes, VS, 2015) |
| "Forty-four women developed preeclampsia." | 1.42 | First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia. ( Bian, Z; Duan, T; Shixia, C, 2015) |
| "Carotid atherosclerosis was evaluated by ultrasonographically determined intima-media thickness (IMT)." | 1.42 | Asymmetric dimethylarginine is associated with high-sensitivity C-reactive protein and early carotid atherosclerosis in women with previous gestational diabetes mellitus. ( Li, D; Shao, Y; Xia, W; Xu, L; Xu, W; Zhang, C, 2015) |
| "Our results allow the conclusion that impaired NO bioavailability in pregnancies complicated by severe preeclampsia and/or IUGR result not from a reduced level or activity of eNOS or from its disturbed intracellular transport, but from increased ADMA levels, an endogenous inhibitor of the enzyme eNOS." | 1.42 | The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction. ( Laskowska, K; Laskowska, M; Oleszczuk, J, 2015) |
| "Decreased DDAH and HO with preeclampsia suggest that they are important points in the regulatory pathways of NO and CO production that are altered in preeclampsia." | 1.39 | Nitric oxide and carbon monoxide production and metabolism in preeclampsia. ( Chan, K; Chen, DB; Ehsanipoor, RM; Fitzmaurice, LE; Fortson, W; Liao, WX; Wing, DA, 2013) |
| " The higher ADMA level after cesarean birth compared with vaginal birth may contribute to decreased nitric oxide production and bioavailability in neonatal vascular beds." | 1.38 | Birth by cesarean section is associated with elevated neonatal plasma levels of dimethylarginines. ( Bode-Böger, SM; Ertl, T; Martens-Lobenhoffer, J; Sulyok, E; Vida, G, 2012) |
| "The development of pulmonary hypertension is a common accompaniment of congenital heart disease (CHD) with increased pulmonary blood flow." | 1.38 | Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I. ( Aramburo, A; Black, SM; Fineman, JR; Kalkan, G; Kallarackal, S; Kumar, S; Rafikov, R; Rehmani, I; Sharma, S; Sun, X; Tian, J, 2012) |
| "Preeclampsia is a syndrome characterized by hypertension and proteinuria." | 1.37 | The role of asymmetric dimethyl arginine and oxidant/antioxidant system in preeclampsia. ( Akalin, S; Akgul, EO; Alacam, H; Aydin, I; Cakir, E; Danisman, N; Deren, O; Dikmen, ZG; Dogan, P; Keskin, U; Kurt, YG; Polat, B; Yaman, H, 2011) |
| "Preeclampsia is a leading cause of intrauterine growth restriction and preterm birth." | 1.35 | Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. ( Braekke, K; Harsem, NK; Staff, AC; Ueland, PM, 2009) |
| "Normal pregnancy is associated with changes in the immune system." | 1.35 | Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy. ( Heinonen, S; Heiskanen, N; Laitinen, T; Lyyra-Laitinen, T; Punnonen, K; Raitakari, OT; Saarelainen, H; Valtonen, P; Viikari, JS, 2009) |
| "From Jan." | 1.35 | [Relationship between changes of endogenous nitric oxide synthase inhibitor and hydrolase and initiation of pre-eclampsia]. ( Chen, DJ; Huang, YY; Liu, HS; Lu, XH; Yao, XB, 2009) |
| " The reduced bioavailability of endothelium-derived nitric oxide (NO) may play a role in endothelial vasodilator dysfunction and the structural changes that are characteristic of GCAD." | 1.33 | Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. ( Cooke, JP; Gunawan, F; Jacobi, J; Robbins, RC; Sydow, K; Tanaka, M; Tsao, PS, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (6.02) | 18.2507 |
| 2000's | 22 (26.51) | 29.6817 |
| 2010's | 51 (61.45) | 24.3611 |
| 2020's | 5 (6.02) | 2.80 |
| Authors | Studies |
|---|---|
| Tiong, P | 3 |
| Kosmider, L | 3 |
| Lassi, ZS | 3 |
| Arstall, MA | 3 |
| Andraweera, PH | 3 |
| Selanno, JF | 1 |
| Riu, DS | 1 |
| Tessy, T | 1 |
| Chalid, MT | 1 |
| Pelupessy, NU | 1 |
| Hartono, E | 1 |
| Ozcelik, HS | 1 |
| Arslan, D | 2 |
| Deniz, CD | 1 |
| Gunenc, O | 1 |
| Vatansev, H | 2 |
| Uysal, C | 1 |
| Dai, Y | 1 |
| Li, TH | 1 |
| He, X | 1 |
| Yan, SB | 1 |
| Gao, Y | 1 |
| Chen, Y | 1 |
| Hsu, CN | 5 |
| Hou, CY | 1 |
| Chang-Chien, GP | 1 |
| Lin, S | 1 |
| Chan, JYH | 1 |
| Lee, CT | 4 |
| Tain, YL | 6 |
| Arya, S | 1 |
| Ye, C | 1 |
| Connelly, PW | 1 |
| Hanley, AJ | 1 |
| Sermer, M | 1 |
| Zinman, B | 1 |
| Retnakaran, R | 1 |
| Lin, YJ | 2 |
| Sheen, JM | 1 |
| Lin, IC | 1 |
| Yu, HR | 1 |
| Huang, LT | 4 |
| Lucovnik, M | 1 |
| Lackner, HK | 1 |
| Papousek, I | 1 |
| Schmid-Zalaudek, K | 1 |
| Schulter, G | 1 |
| Roessler, A | 1 |
| Moertl, MG | 1 |
| Maruta, E | 1 |
| Wang, J | 1 |
| Kotani, T | 1 |
| Tsuda, H | 1 |
| Nakano, T | 1 |
| Imai, K | 1 |
| Sumigama, S | 1 |
| Niwa, Y | 1 |
| Mitsui, T | 1 |
| Yoshida, S | 1 |
| Yamashita, M | 1 |
| Nawa, A | 1 |
| Tamakoshi, K | 1 |
| Kajiyama, H | 1 |
| Kikkawa, F | 1 |
| Tsikas, D | 3 |
| Bollenbach, A | 1 |
| Savvidou, MD | 2 |
| Bjørke-Jenssen, A | 1 |
| Ueland, PM | 3 |
| Bjørke-Monsen, AL | 1 |
| McDonald, CR | 1 |
| Cahill, LS | 1 |
| Gamble, JL | 1 |
| Elphinstone, R | 1 |
| Gazdzinski, LM | 1 |
| Zhong, KJY | 1 |
| Philson, AC | 1 |
| Madanitsa, M | 1 |
| Kalilani-Phiri, L | 1 |
| Mwapasa, V | 1 |
| Ter Kuile, FO | 1 |
| Sled, JG | 1 |
| Conroy, AL | 1 |
| Kain, KC | 1 |
| Garg, P | 1 |
| Jaryal, AK | 1 |
| Kachhawa, G | 1 |
| Deepak, KK | 1 |
| Kriplani, A | 1 |
| Németh, B | 1 |
| Murányi, E | 1 |
| Hegyi, P | 1 |
| Mátrai, P | 1 |
| Szakács, Z | 1 |
| Varjú, P | 1 |
| Hamvas, S | 1 |
| Tinusz, B | 1 |
| Budán, F | 1 |
| Czimmer, J | 1 |
| Bérczi, B | 1 |
| Erőss, B | 1 |
| Gyöngyi, Z | 1 |
| Kiss, I | 1 |
| He, Q | 1 |
| Liu, X | 1 |
| Zhong, Y | 1 |
| Xu, SS | 1 |
| Zhang, ZM | 1 |
| Tang, LL | 1 |
| Zhang, LY | 1 |
| Du, LZ | 1 |
| Dymara-Konopka, W | 1 |
| Laskowska, M | 5 |
| El-Saka, MH | 1 |
| Madi, NM | 1 |
| Ibrahim, RR | 1 |
| Alghazaly, GM | 1 |
| Elshwaikh, S | 1 |
| El-Bermawy, M | 1 |
| Lee, WC | 2 |
| Lin, CY | 1 |
| Oran, B | 1 |
| Cimen, D | 1 |
| Guvenc, O | 1 |
| Laskowska, K | 4 |
| Terbosh, M | 1 |
| Oleszczuk, J | 5 |
| Tamás, P | 1 |
| Bódis, J | 1 |
| Sulyok, E | 3 |
| Kovács, GL | 1 |
| Hantosi, E | 1 |
| Molnár, G | 1 |
| Martens-Lobenhoffer, J | 3 |
| Bode-Böger, SM | 3 |
| Alpoim, PN | 1 |
| Godoi, LC | 1 |
| Freitas, LG | 1 |
| Gomes, KB | 1 |
| Dusse, LM | 1 |
| Bassareo, PP | 1 |
| Fanos, V | 1 |
| Mussap, M | 1 |
| Flore, G | 1 |
| Noto, A | 1 |
| Puddu, M | 1 |
| Saba, L | 1 |
| Mercuro, G | 1 |
| Chiavaroli, V | 1 |
| Diesse, L | 1 |
| de Giorgis, T | 1 |
| Giannini, C | 1 |
| Marcovecchio, ML | 1 |
| Chiarelli, F | 1 |
| Mohn, A | 1 |
| Xia, W | 1 |
| Li, D | 1 |
| Zhang, C | 1 |
| Xu, L | 1 |
| Xu, W | 1 |
| Shao, Y | 1 |
| Bian, Z | 1 |
| Shixia, C | 1 |
| Duan, T | 1 |
| Tousoulis, D | 1 |
| Georgakis, MK | 1 |
| Oikonomou, E | 1 |
| Papageorgiou, N | 1 |
| Zaromitidou, M | 1 |
| Latsios, G | 1 |
| Papaioannou, S | 1 |
| Siasos, G | 1 |
| López-Alarcón, M | 2 |
| Montalvo-Velarde, I | 2 |
| Vital-Reyes, VS | 2 |
| Hinojosa-Cruz, JC | 2 |
| Leaños-Miranda, A | 1 |
| Martínez-Basila, A | 1 |
| Puellotamara, E | 1 |
| Poniedziałek-Czajkowska, E | 1 |
| Mierzyński, R | 1 |
| Szymula, D | 1 |
| Leszczyńska-Gorzelak, B | 2 |
| Tsai, CC | 1 |
| Mayer-Pickel, K | 1 |
| Kolovetsiou-Kreiner, V | 1 |
| Mörtl, MG | 1 |
| Schlembach, D | 1 |
| Eberhard, K | 1 |
| Obermayer-Pietsch, B | 1 |
| Lang, U | 1 |
| Cervar-Zivkovic, M | 1 |
| Karampas, GA | 1 |
| Eleftheriades, MI | 1 |
| Panoulis, KC | 1 |
| Rizou, MD | 1 |
| Haliassos, AD | 1 |
| Metallinou, DK | 1 |
| Mastorakos, GP | 1 |
| Rizos, DA | 1 |
| Mora-Fernández, C | 1 |
| Jarque, A | 1 |
| Getino, MA | 1 |
| Sánchez, R | 1 |
| Lozano, L | 1 |
| Navarro, JF | 1 |
| Telejko, B | 1 |
| Zonenberg, A | 1 |
| Kuzmicki, M | 1 |
| Modzelewska, A | 1 |
| Niedziolko-Bagniuk, K | 1 |
| Ponurkiewicz, A | 1 |
| Nikolajuk, A | 1 |
| Gorska, M | 1 |
| Valtonen, P | 1 |
| Punnonen, K | 1 |
| Saarelainen, H | 1 |
| Heiskanen, N | 1 |
| Raitakari, OT | 1 |
| Viikari, JS | 1 |
| Lyyra-Laitinen, T | 1 |
| Laitinen, T | 1 |
| Heinonen, S | 1 |
| Huang, YY | 1 |
| Yao, XB | 1 |
| Lu, XH | 1 |
| Liu, HS | 1 |
| Chen, DJ | 1 |
| Braekke, K | 1 |
| Harsem, NK | 1 |
| Staff, AC | 1 |
| Shaw, GM | 1 |
| Vollset, SE | 1 |
| Carmichael, SL | 1 |
| Yang, W | 1 |
| Finnell, RH | 1 |
| Blom, H | 1 |
| Mao, D | 1 |
| Che, J | 1 |
| Li, K | 1 |
| Han, S | 1 |
| Yue, Q | 1 |
| Zhu, L | 1 |
| Zhang, W | 1 |
| Li, L | 1 |
| Böger, RH | 3 |
| Diemert, A | 1 |
| Schwedhelm, E | 2 |
| Lüneburg, N | 1 |
| Maas, R | 2 |
| Hecher, K | 1 |
| Sandrim, VC | 1 |
| Palei, AC | 1 |
| Metzger, IF | 1 |
| Cavalli, RC | 1 |
| Duarte, G | 1 |
| Tanus-Santos, JE | 1 |
| Turan, F | 1 |
| Ilhan, N | 1 |
| Kaman, D | 1 |
| Ateş, K | 1 |
| Kafkasli, A | 2 |
| Akturk, M | 1 |
| Altinova, A | 1 |
| Mert, I | 1 |
| Dincel, A | 1 |
| Sargin, A | 1 |
| Buyukkagnici, U | 1 |
| Arslan, M | 1 |
| Danisman, N | 2 |
| Alfiero Bordigato, M | 1 |
| Piva, D | 1 |
| Di Gangi, IM | 1 |
| Giordano, G | 1 |
| Chiandetti, L | 1 |
| Filippone, M | 1 |
| Sertkaya, AC | 1 |
| Turkcuoglu, I | 1 |
| Karabulut, AB | 1 |
| Rizos, D | 1 |
| Eleftheriades, M | 1 |
| Batakis, E | 1 |
| Rizou, M | 1 |
| Haliassos, A | 1 |
| Hassiakos, D | 1 |
| Botsis, D | 1 |
| Alacam, H | 1 |
| Dikmen, ZG | 1 |
| Yaman, H | 1 |
| Cakir, E | 1 |
| Deren, O | 1 |
| Akgul, EO | 1 |
| Aydin, I | 1 |
| Kurt, YG | 1 |
| Keskin, U | 1 |
| Akalin, S | 1 |
| Polat, B | 1 |
| Dogan, P | 1 |
| Khalil, AA | 1 |
| Akolekar, R | 1 |
| Jordan, J | 1 |
| Nicolaides, KH | 2 |
| Vida, G | 2 |
| Ertl, T | 2 |
| Gumus, II | 1 |
| Kargili, A | 1 |
| Kaygusuz, I | 1 |
| Derbent, A | 1 |
| Karakurt, F | 1 |
| Kasapoglu, B | 1 |
| Uysal, S | 1 |
| Sharma, S | 1 |
| Sun, X | 1 |
| Kumar, S | 1 |
| Rafikov, R | 1 |
| Aramburo, A | 1 |
| Kalkan, G | 1 |
| Tian, J | 1 |
| Rehmani, I | 1 |
| Kallarackal, S | 1 |
| Fineman, JR | 1 |
| Black, SM | 1 |
| Demir, B | 1 |
| Demir, S | 1 |
| Pasa, S | 1 |
| Guven, S | 1 |
| Atamer, Y | 1 |
| Atamer, A | 1 |
| Kocyigit, Y | 1 |
| Masoura, S | 1 |
| Kalogiannidis, IA | 1 |
| Gitas, G | 1 |
| Goutsioulis, A | 1 |
| Koiou, E | 1 |
| Athanasiadis, A | 1 |
| Vavatsi, N | 1 |
| Ehsanipoor, RM | 1 |
| Fortson, W | 1 |
| Fitzmaurice, LE | 1 |
| Liao, WX | 1 |
| Wing, DA | 1 |
| Chen, DB | 1 |
| Chan, K | 1 |
| Pisaneschi, S | 1 |
| Strigini, FA | 1 |
| Sanchez, AM | 1 |
| Begliuomini, S | 1 |
| Casarosa, E | 1 |
| Ripoli, A | 1 |
| Ghirri, P | 1 |
| Boldrini, A | 1 |
| Fink, B | 1 |
| Genazzani, AR | 2 |
| Coceani, F | 1 |
| Simoncini, T | 2 |
| Chedraui, P | 1 |
| Solis, EJ | 1 |
| Bocci, G | 1 |
| Gopal, S | 1 |
| Russo, E | 1 |
| Escobar, GS | 1 |
| Hidalgo, L | 1 |
| Pérez-López, FR | 1 |
| Mannella, P | 1 |
| Hsieh, CS | 1 |
| Chang, KA | 1 |
| Mittermayer, F | 2 |
| Mayer, BX | 1 |
| Meyer, A | 1 |
| Winzer, C | 2 |
| Pacini, G | 2 |
| Wagner, OF | 1 |
| Wolzt, M | 2 |
| Kautzky-Willer, A | 2 |
| Maeda, T | 1 |
| Yoshimura, T | 1 |
| Okamura, H | 1 |
| Hingorani, AD | 1 |
| Frölich, JC | 1 |
| Vallance, P | 3 |
| Casas, JP | 1 |
| López-Jaramillo, P | 1 |
| Serrano, N | 1 |
| Díaz, LA | 1 |
| Leiper, J | 1 |
| Tanaka, M | 1 |
| Sydow, K | 1 |
| Gunawan, F | 1 |
| Jacobi, J | 1 |
| Tsao, PS | 1 |
| Robbins, RC | 1 |
| Cooke, JP | 1 |
| Herrmann, W | 1 |
| Isber, S | 1 |
| Obeid, R | 1 |
| Herrmann, M | 1 |
| Jouma, M | 1 |
| Markov, KhM | 1 |
| Slaghekke, F | 1 |
| Dekker, G | 1 |
| Jeffries, B | 1 |
| Pleiner, J | 1 |
| Langenberger, H | 1 |
| Schaller, G | 1 |
| Tura, A | 1 |
| Speer, PD | 1 |
| Powers, RW | 1 |
| Frank, MP | 1 |
| Harger, G | 1 |
| Markovic, N | 1 |
| Roberts, JM | 1 |
| Tsukahara, H | 1 |
| Ohta, N | 2 |
| Tokuriki, S | 1 |
| Nishijima, K | 1 |
| Kotsuji, F | 1 |
| Kawakami, H | 1 |
| Sekine, K | 1 |
| Nagasaka, H | 1 |
| Mayumi, M | 1 |
| Prefumo, F | 1 |
| Thilaganathan, B | 1 |
| Whitley, GS | 2 |
| Fickling, SA | 1 |
| Williams, D | 1 |
| Nussey, SS | 1 |
| King, RG | 1 |
| Di Iulio, JL | 1 |
| Gude, NM | 1 |
| Brennecke, SP | 1 |
| Chen, BM | 1 |
| Xia, LW | 1 |
| Zhao, RQ | 1 |
| Egberts, J | 2 |
| van den Bosch, N | 2 |
| Brand, R | 1 |
| Soederhuizen, P | 1 |
| Ellis, J | 1 |
| Wennerholm, UB | 1 |
| Bengtsson, A | 1 |
| Lilja, H | 1 |
| Pettersson, A | 1 |
| Sultan, B | 1 |
| Wennergren, M | 1 |
| Hagberg, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1 Study of the Safety and Pharmacokinetics of Perioperative IV L-carnitine Administration in Patients With Congenital Heart Disease With Increased Pulmonary Blood Flow[NCT01825369] | Phase 1 | 0 participants (Actual) | Interventional | 2014-12-31 | Withdrawn (stopped due to Changes to cardiac surgery program) | ||
| Vascular Endothelial Growth Factor C/A 2578 Gene Polymorphism and Umbilical Artery Doppler in Preeclamptic Women[NCT03500588] | 290 participants (Actual) | Observational | 2017-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for n(g),n(g')-dimethyl-l-arginine and Pregnancy
| Article | Year |
|---|---|
Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis.
Topics: Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Humans; Postpartum Period; Pregnan | 2023 |
Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis.
Topics: Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Humans; Postpartum Period; Pregnan | 2023 |
Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis.
Topics: Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Humans; Postpartum Period; Pregnan | 2023 |
Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis.
Topics: Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Humans; Postpartum Period; Pregnan | 2023 |
Asymmetric dimethylarginine levels in preeclampsia - Systematic review and meta-analysis.
Topics: Arginine; Biomarkers; Female; Humans; Pre-Eclampsia; Pregnancy | 2018 |
The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia-Review.
Topics: Arginine; Female; Homocysteine; Humans; Nitric Oxide; Pre-Eclampsia; Pregnancy; Signal Transduction | 2019 |
Is asymmetric dimethylarginine associated with being born small and large for gestational age?
Topics: Arginine; Biomarkers; Birth Weight; Cardiovascular Diseases; Female; Gestational Age; Humans; Metabo | 2014 |
Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches.
Topics: Alzheimer Disease; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hy | 2015 |
[Novelties in the field of progression factors in chronic kidney disease].
Topics: Adult; Amidohydrolases; Animals; Arginine; Carbon; Cardiovascular Diseases; Chronic Disease; Clinica | 2008 |
The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia.
Topics: Arginine; Biomarkers; Endothelium, Vascular; Female; Humans; Nitric Oxide Synthase; Pre-Eclampsia; P | 2010 |
Biomarkers in pre-eclampsia: a novel approach to early detection of the disease.
Topics: Antigens, CD; Arginine; Biomarkers; Endoglin; Female; Galectins; Homocysteine; Humans; Leptin; Pre-E | 2012 |
Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming.
Topics: Animals; Arginine; Female; Fetal Development; Humans; Metabolic Networks and Pathways; Nitric Oxide; | 2012 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Dise | 2004 |
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; | 2004 |
[Molecular mechanisms of dysfunction of vascular endothelium].
Topics: Adult; Animals; Apoptosis; Arginine; Atherosclerosis; Cardiovascular Diseases; Cells, Cultured; Chil | 2005 |
Endogenous inhibitors of nitric oxide and preeclampsia: a review.
Topics: Amidohydrolases; Arginine; Endothelium, Vascular; Female; Humans; Nitric Oxide; Nitric Oxide Synthas | 2006 |
70 other studies available for n(g),n(g')-dimethyl-l-arginine and Pregnancy
| Article | Year |
|---|---|
Maternal serum levels of asymmetric dimethylarginine in normal and preeclamptic pregnancies.
Topics: Adult; Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Fetal Growth Retardation; Hu | 2020 |
Evaluation of Plasma Asymmetric Dimethylarginine Levels and Abdominal Aortic Intima-Media Thickness in Infants of Smoker Mothers.
Topics: Adult; Aorta, Abdominal; Arginine; Case-Control Studies; Cigarette Smoking; Echocardiography; Female | 2021 |
The Effect and Mechanism of Asymmetric Dimethylarginine Regulating Trophoblastic Autophagy on Fetal Growth Restriction.
Topics: Adenine; Adult; Arginine; Autophagy; Beclin-1; Cell Line, Tumor; Female; Fetal Growth Retardation; H | 2021 |
Maternal resveratrol therapy protected adult rat offspring against hypertension programmed by combined exposures to asymmetric dimethylarginine and trimethylamine-N-oxide.
Topics: Animals; Antioxidants; Arginine; Female; Gastrointestinal Microbiome; Hypertension; Methylamines; Pr | 2021 |
Asymmetric dimethylarginine and arginine metabolites in women with and without a history of gestational diabetes.
Topics: Adult; Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Follow-Up Studies; Glucose | 2017 |
Resveratrol prevents the combined maternal plus postweaning high-fat-diets-induced hypertension in male offspring.
Topics: Animals; Arginine; Blood Pressure; Diet, High-Fat; Female; Hypertension; Male; Maternal Nutritional | 2017 |
Systemic vascular resistance and endogenous inhibitors of nitric oxide synthesis in early- compared to late-onset preeclampsia: preliminary findings.
Topics: Adult; Arginine; Case-Control Studies; Female; Humans; Pre-Eclampsia; Pregnancy; Vascular Resistance | 2017 |
Association of serum asymmetric dimethylarginine, homocysteine, and l-arginine concentrations during early pregnancy with hypertensive disorders of pregnancy.
Topics: Adult; Area Under Curve; Arginine; Biomarkers; Body Mass Index; Case-Control Studies; Female; Gestat | 2017 |
Inverse correlation between maternal plasma asymmetric dimethylarginine (ADMA) and birthweight percentile in women with impaired placental perfusion: circulating ADMA as an NO-independent indicator of fetal growth restriction?
Topics: Adult; Arginine; Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Fetus; Gestational Age; | 2018 |
Amniotic Fluid Arginine from Gestational Weeks 13 to 15 Is a Predictor of Birth Weight, Length, and Head Circumference.
Topics: Adult; Amniotic Fluid; Arginine; Birth Weight; Dietary Supplements; Female; Fetal Growth Retardation | 2017 |
Malaria in pregnancy alters l-arginine bioavailability and placental vascular development.
Topics: Animals; Arginine; Female; Humans; Malaria; Mice; Nitric Oxide; Placenta; Pregnancy; Pregnancy Outco | 2018 |
Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; | 2018 |
Arginine bioavailability and endothelin-1 system in the regulation of vascular function of umbilical vein endothelial cells from intrauterine growth restricted newborns.
Topics: Adult; Amidohydrolases; Arginase; Arginine; Case-Control Studies; Cell Proliferation; Cells, Culture | 2018 |
The ameliorative effect of angiotensin 1-7 on experimentally induced-preeclampsia in rats: Targeting the role of peroxisome proliferator-activated receptors gamma expression & asymmetric dimethylarginine.
Topics: Angiotensin I; Animals; Arginine; Blood Pressure; Female; Oxidative Stress; Peptide Fragments; Place | 2019 |
Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers.
Topics: Animals; Arginine; Blotting, Western; Electron Spin Resonance Spectroscopy; Female; Hypertension; Ki | 2013 |
The usefulness of plasma asymmetric dimethylarginine (ADMA) levels and tissue doppler echocardiography for heart function in term infants born to mothers with gestational diabetes mellitus.
Topics: Arginine; Case-Control Studies; Diabetes, Gestational; Echocardiography, Doppler; Female; Heart; Hum | 2013 |
A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies.
Topics: Adult; Arginine; Case-Control Studies; Female; Homocysteine; Humans; Nitric Oxide Synthase Type III; | 2013 |
L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Female; Fetal Blood; Humans; omega-N-Methylargini | 2013 |
Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia.
Topics: Arginine; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Nitric Oxide; Pre | 2013 |
Urinary NGAL and hematic ADMA levels: an early sign of cardio-renal syndrome in young adults born preterm?
Topics: Acute-Phase Proteins; Adolescent; Adult; Adult Children; Arginine; Cardio-Renal Syndrome; Case-Contr | 2013 |
The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction.
Topics: Adaptor Proteins, Signal Transducing; Adult; Arginine; Case-Control Studies; DNA-Binding Proteins; F | 2015 |
Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction.
Topics: Animals; Arginine; Caloric Restriction; Female; Hypertension; In Vitro Techniques; Kidney; Male; Mel | 2014 |
Asymmetric dimethylarginine is associated with high-sensitivity C-reactive protein and early carotid atherosclerosis in women with previous gestational diabetes mellitus.
Topics: Adult; Arginine; C-Reactive Protein; Carotid Artery Diseases; Carotid Intima-Media Thickness; Diabet | 2015 |
First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
Topics: Adult; Area Under Curve; Arginine; Blood Pressure; Case-Control Studies; Demography; Female; Follow- | 2015 |
Serial determinations of asymmetric dimethylarginine and homocysteine during pregnancy to predict pre-eclampsia: a longitudinal study.
Topics: Adult; Arginine; Biomarkers; Body Mass Index; Female; Folic Acid; Follow-Up Studies; Homocysteine; H | 2015 |
[Interactions between markers of endothelial damage (homocysteine and asymmetric dimethylarginine) and antioxidants and B-vitamins in preeclamptic women].
Topics: Adolescent; Adult; Antioxidants; Arginine; Biomarkers; Cross-Sectional Studies; Female; Homocysteine | 2015 |
Intercellular Adhesion Molecule and Endogenous NOS Inhibitor: Asymmetric Dimethylarginine in Pregnant Women with Gestational Diabetes Mellitus.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Diabetes, Gestational; Enzyme-Linked Immunosorben | 2016 |
N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers.
Topics: Acetylcysteine; Animals; Arginine; Blood Pressure; Female; Fetal Development; Hydrogen Sulfide; Hype | 2016 |
Endothelin 1, ADMA and SDMA in pregnancies with obstetric and thrombotic antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Arginine; Chronic Disease; Endothelin-1; Endothelium, Vascular; Fe | 2016 |
Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.
Topics: Adult; Arginine; Biomarkers; Female; Humans; Lipocalin-2; Matrix Metalloproteinase 9; Pilot Projects | 2016 |
Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes.
Topics: Adult; Arginine; Blood Glucose; Case-Control Studies; Diabetes, Gestational; Endothelin-1; Female; H | 2009 |
Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Creatinine; Cytokines; Enzyme Inhibitors; Female; G | 2009 |
[Relationship between changes of endogenous nitric oxide synthase inhibitor and hydrolase and initiation of pre-eclampsia].
Topics: Adult; Amidohydrolases; Arginine; Chromatography, High Pressure Liquid; Female; Humans; Nitric Oxide | 2009 |
Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia.
Topics: Adult; Arginine; Female; Fetus; Humans; Infant, Newborn; Maternal-Fetal Exchange; Nitric Oxide; Pre- | 2009 |
Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate.
Topics: Adult; Arginine; Carbon; Case-Control Studies; Cleft Lip; Cleft Palate; Dietary Supplements; Female; | 2009 |
Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia.
Topics: Arginine; Biomarkers; Case-Control Studies; Chromatography, Liquid; Endothelium-Dependent Relaxing F | 2010 |
Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia.
Topics: Adult; Arginine; Biomarkers; Black People; Case-Control Studies; Ethnicity; Female; Humans; Nitric O | 2010 |
Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation.
Topics: Adult; Analysis of Variance; Arginine; Chromatography, High Pressure Liquid; Female; Fetal Growth Re | 2010 |
Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes.
Topics: Adolescent; Adult; Arginine; C-Reactive Protein; Diabetes, Gestational; Female; Homocysteine; Humans | 2010 |
Asymmetric dimethylarginine in ELBW newborns exposed to chorioamnionitis.
Topics: Arginine; Chorioamnionitis; Female; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Inf | 2011 |
Asymmetric dimethylarginine in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women with and without intrauterine growth restriction.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Female; Fetal Growth Retardation; Humans; Pre-Ecl | 2011 |
Asymmetric dimethylarginine level in hyperglycemic gestation.
Topics: Adult; Arginine; Blood Glucose; Body Mass Index; Case-Control Studies; Chromatography, High Pressure | 2011 |
Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby.
Topics: Adult; Arginine; Blood Chemical Analysis; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; F | 2012 |
The role of asymmetric dimethyl arginine and oxidant/antioxidant system in preeclampsia.
Topics: Adult; Antioxidants; Arginine; Case-Control Studies; Citrulline; Female; Fetal Blood; Humans; Lipid | 2011 |
Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study.
Topics: Adult; Arginine; Case-Control Studies; Female; Gas Chromatography-Mass Spectrometry; Homoarginine; H | 2013 |
Birth by cesarean section is associated with elevated neonatal plasma levels of dimethylarginines.
Topics: Arginine; Cesarean Section; Delivery, Obstetric; Female; Humans; Infant, Newborn; Male; Pregnancy | 2012 |
The association between serum asymmetric dimethyl arginine levels and a history of gestational diabetes among healthy women.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular D | 2012 |
Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I.
Topics: Acetylcarnitine; Adaptor Proteins, Signal Transducing; Animals; Animals, Newborn; Arginine; Biopteri | 2012 |
The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia.
Topics: Adult; Arginine; Case-Control Studies; Female; Homocysteine; Humans; Nitric Oxide; Pre-Eclampsia; Pr | 2012 |
Nitric oxide and carbon monoxide production and metabolism in preeclampsia.
Topics: Adult; Amidohydrolases; Arginine; Biomarkers; Blotting, Western; Carbon Monoxide; Case-Control Studi | 2013 |
Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction.
Topics: Adaptation, Physiological; Adult; Arginine; Endothelial Cells; Endothelium, Vascular; Female; Fetal | 2012 |
Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia.
Topics: Adolescent; Adult; Arginine; Case-Control Studies; Female; Fetal Blood; Genetic Predisposition to Di | 2013 |
Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction.
Topics: Adult; Arginine; Case-Control Studies; Female; Fetal Growth Retardation; Homocysteine; Humans; Pre-E | 2013 |
Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes.
Topics: Adult; Arginine; Biomarkers; Body Mass Index; Diabetes, Gestational; Female; Follow-Up Studies; Huma | 2002 |
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation.
Topics: Adolescent; Adult; Arginine; Enzyme Inhibitors; Female; Fetal Blood; Gestational Age; Humans; Labor, | 2003 |
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.
Topics: Arginine; Brachial Artery; Endothelium, Vascular; Female; Humans; Placental Circulation; Pre-Eclamps | 2003 |
Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia.
Topics: Adult; Arginine; Case-Control Studies; Colombia; Female; Humans; Pre-Eclampsia; Pregnancy | 2004 |
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.
Topics: Amidohydrolases; Animals; Arginine; Coronary Artery Disease; Cytokines; Enzyme Inhibitors; Female; H | 2005 |
Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status.
Topics: Adult; Arginine; Female; Homocysteine; Humans; Nutritional Status; Pre-Eclampsia; Pregnancy; Time Fa | 2005 |
Plasma asymmetric dimethylarginine concentration during the perinatal period.
Topics: Adult; Arginine; Blood Circulation; Endothelium, Vascular; Female; Humans; Infant, Newborn; Nitric O | 2007 |
Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes.
Topics: Adult; Arginine; Body Mass Index; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diabetic Angiopa | 2007 |
Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Female; Humans; Infant, Newborn; Infant, Small fo | 2008 |
Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood.
Topics: Adolescent; Adult; Arginine; Child; Child, Preschool; Enzyme Inhibitors; Female; Fetal Blood; Humans | 2008 |
First-trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine.
Topics: Adult; Arginine; Arteries; Blood Pressure; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Trime | 2008 |
Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia.
Topics: Animals; Arginine; Female; Humans; Hypertension; Nitric Oxide; Pre-Eclampsia; Pregnancy; Pregnancy C | 1993 |
Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and pre-eclamptic placentae.
Topics: Arginine; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Nitric Oxide Synthase; Placenta; P | 1995 |
Determination of N(G),N(G)-dimethylarginine in human plasma by high-performance liquid chromatography.
Topics: Amino Acids; Arginine; Chromatography, High Pressure Liquid; Female; Humans; Pregnancy; Pregnancy Co | 1997 |
Nitric oxide metabolites, cyclic guanosine 3,5 monophosphate and dimethylarginines during and after uncomplicated pregnancies: a longitudinal study.
Topics: Adult; Arginine; Chromatography, High Pressure Liquid; Creatinine; Cyclic GMP; Enzyme Inhibitors; Et | 1999 |
Amniotic fluid nitric oxide metabolites, cyclic guanosine 3',5' monophosphate and dimethylarginine in alloimmunized pregnancies.
Topics: Amniocentesis; Amniotic Fluid; Arginine; Blood Transfusion, Intrauterine; Creatinine; Cyclic GMP; Em | 1999 |
Levels of dimethylarginines and cytokines in mild and severe preeclampsia.
Topics: Arginine; Blood Pressure; Cytokines; Female; Gestational Age; Humans; Nitric Oxide Synthase; Pre-Ecl | 2001 |